Insights from 2024 ESGO Annual Meeting


 

ESGO 2024 Insights: "SENTIX Trial - Survival of Patients With Early Stages Cervical Cancer After SLN Biopsy Without Systematic Pelvic Lymphadenectomy"

0 views
April 19, 2024
Comments 0
Login to view comments. Click here to Login